Merck & Co Company News

Merck is pharma’s most patent-exposed company. Now it’s reinventing itself. - Pharma Voice

Merck is pharma’s most patent-exposed company. Now it’s reinventing itself. Pharma Voice

Merck & Co. ups sales guidance as newer drugs grow alongside Keytruda - FirstWord Pharma

Merck & Co. ups sales guidance as newer drugs grow alongside Keytruda FirstWord Pharma

Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline - Yahoo Finance

Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline Yahoo Finance

Merck & Co., Inc. $MRK Shares Bought by Dynamic Advisor Solutions LLC - MarketBeat

Merck & Co., Inc. $MRK Shares Bought by Dynamic Advisor Solutions LLC MarketBeat

Merck & Co. Inc. stock underperforms Monday when compared to competitors - MarketWatch

Merck & Co. Inc. stock underperforms Monday when compared to competitors MarketWatch

Merck posts better-than-expected second-quarter results on Keytruda strength - BNN Bloomberg

Merck posts better-than-expected second-quarter results on Keytruda strength BNN Bloomberg

Merck Announces Fourth-Quarter 2026 Dividend - Business Wire

Merck Announces Fourth-Quarter 2026 Dividend Business Wire

Our Q4 and full-year 2025 financial results - Merck

Our Q4 and full-year 2025 financial results Merck

Merck to split cancer, specialty drug businesses in leadership shakeup - BioPharma Dive

Merck to split cancer, specialty drug businesses in leadership shakeup BioPharma Dive

Merck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment - Fierce Pharma

Merck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment Fierce Pharma

Merck licenses experimental HIV pill to generic makers in 129 countries - Reuters

Merck licenses experimental HIV pill to generic makers in 129 countries Reuters

Merck & Co., Inc. Q2 Earnings Call Highlights - MarketBeat

Merck & Co., Inc. Q2 Earnings Call Highlights MarketBeat

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - CNBC

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline CNBC

FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir) - Merck

FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir) Merck

Girding against Keytruda cliff, Merck splits oncology into standalone business unit - Fierce Pharma

Girding against Keytruda cliff, Merck splits oncology into standalone business unit Fierce Pharma

Canandaigua National Bank & Trust Co. Buys New Shares in Merck & Co., Inc. $MRK - MarketBeat

Canandaigua National Bank & Trust Co. Buys New Shares in Merck & Co., Inc. $MRK MarketBeat

The new manufacturing facilities powering our US growth - Merck

The new manufacturing facilities powering our US growth Merck

Merck & Co., Inc. $MRK Shares Sold by Pacer Advisors Inc. - MarketBeat

Merck & Co., Inc. $MRK Shares Sold by Pacer Advisors Inc. MarketBeat

Centaurus Financial Inc. Sells 19,825 Shares of Merck & Co., Inc. $MRK - MarketBeat

Centaurus Financial Inc. Sells 19,825 Shares of Merck & Co., Inc. $MRK MarketBeat

Merck & Co.'s Keytruda posts $8B in Q1 as Qlex picks up steam - FirstWord Pharma

Merck & Co.'s Keytruda posts $8B in Q1 as Qlex picks up steam FirstWord Pharma

Earnings Preview: What To Expect From Merck & Co.'s Report - Yahoo Finance

Earnings Preview: What To Expect From Merck & Co.'s Report Yahoo Finance

Do Wall Street Analysts Like Merck & Co. Stock? - Yahoo Finance

Do Wall Street Analysts Like Merck & Co. Stock? Yahoo Finance

‘Unacceptable’: Lawmakers react to revelations from ICIJ’s Cancer Calculus investigation - International Consortium of Investigative Journalists - ICIJ

‘Unacceptable’: Lawmakers react to revelations from ICIJ’s Cancer Calculus investigation International Consortium of Investigative Journalists - ICIJ

Merck & Co., Inc. $MRK is Compass Capital Management Inc.'s 2nd Largest Position - MarketBeat

Merck & Co., Inc. $MRK is Compass Capital Management Inc.'s 2nd Largest Position MarketBeat

Germany's Merck boosts life sciences business with $11 billion bet on Bio-Techne - Reuters

Germany's Merck boosts life sciences business with $11 billion bet on Bio-Techne Reuters

Merck & Co. (MRK) Announces Quarterly Dividend - Yahoo Finance

Merck & Co. (MRK) Announces Quarterly Dividend Yahoo Finance

Merck & Co. (MRK): Our Calculation of Intrinsic Value - The Acquirer's Multiple

Merck & Co. (MRK): Our Calculation of Intrinsic Value The Acquirer's Multiple

Top Research Reports for Merck, Southern Company & Lumentum - Yahoo Finance

Top Research Reports for Merck, Southern Company & Lumentum Yahoo Finance

Merck exec says company is discussing use of COVID antiviral drug in Ebola response - Reuters

Merck exec says company is discussing use of COVID antiviral drug in Ebola response Reuters

How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide - International Consortium of Investigative Journalists - ICIJ

How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide International Consortium of Investigative Journalists - ICIJ

Merck shrinks headcount by 88 in New Jersey as $3B cost-cutting scheme advances - Fierce Pharma

Merck shrinks headcount by 88 in New Jersey as $3B cost-cutting scheme advances Fierce Pharma

Merck’s deal for Terns sparks debate over a possible biotech bidding war - BioPharma Dive

Merck’s deal for Terns sparks debate over a possible biotech bidding war BioPharma Dive

Merck & Co. hunts new drug candidates with Protillion in $510M AI deal - FirstWord Pharma

Merck & Co. hunts new drug candidates with Protillion in $510M AI deal FirstWord Pharma

Merck to buy Terns in $6.7B bet on a ‘differentiated’ leukemia drug - BioPharma Dive

Merck to buy Terns in $6.7B bet on a ‘differentiated’ leukemia drug BioPharma Dive

Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine - Mayo Clinic News Network

Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine Mayo Clinic News Network